SETD2 and renal cell carcinoma: Taken together, our results reveal that SETD2-mediated redistribution of m6A and its associated changes in gene expression target essential RCC genes associated with the known metabolic shift in SETD2 deficient cells away from fatty acid accumulation and toward increased peroxisomal and mitochondrial oxidation [30].